Carcinogen specificity in the activation of transforming genes by direct-acting alkylating agents.
Carcinogen specificity in the activation of transforming genes by direct-acting alkylating agents.
复制标题
直接作用烷化剂激活转化基因的致癌特异性。
DOI:
10.1093/carcin/6.12.1709
复制
发表时间:
1985
期刊:
影响因子:
4.7
通讯作者:
Albert,RE
中科院分区:
文献类型:
--
作者:
Garte,SJ;Hood,AT;Hochwalt,AE;D'Eustachio,P;Snyder,CA;Segal,A;Albert,RE
DNAs from rat nasal and mouse skin carcinomas and fibrosarcomas induced by the alkylating agents methylmethane sulfonate (MMS), β-propiolactone (BPL), and dimethyl-carbamyl chloride (DMCC) were tested for their ability to transform NIH3T3 cells by DNA transfection. Each of eight MMS-induced rat nasal carcinomas and two of five BPL-induced mouse skin tumors were positive in the transfection assay while all of four fibrosarcomas and six carcinomas induced by DMCC were negative. Anchorage independent growth, tumorigenicity in nude mice, and secondary transfection confirmed the transformed phenotype of the positive transfectants. The transfectants from MMS-induced tumor DNAs did not contain restriction fragments homologous to rat H-, K- or N-ras oncogenes although exogenous (rat) tumor-derived DNA sequences were detected in transfectant genomes by Southern analysis. In contrast a BPL-induced mouse skin tumor showed evidence of containing activated H-ras. These results suggest specificity among causal carcinogens for activation of transforming genes in experimental tumors.